Sector Investors News and Insights

Director Steven Galson has purchased 21,940 shares of BioCryst Pharmaceuticals Inc (BCRX).

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com